Figure 4From: Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancerCorrelations between PCDH8 methylation and five-year overall survival in NMIBC patients. Patients with PCDH8 methylated showed significantly shorter five-year overall survival than patients without (P = 0.0177, log-rank test).Back to article page